Insulin secretion and interleukin-1β dependent mechanisms in human diabetes remission after metabolic surgery

Current Medicinal Chemistry

Volumn 20, Issue 18, 2013, Pages 2374-2388

  Chen, Chih Yen ^a,b   Lee, Wei Jei ^c   Asakawa, A ^d   Fujitsuka, N ^d   Chong, Keong ^c   Chen, Shu Chun ^c   Lee, Shou Dong ^a,b,e   Inui, A ^d  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c MIN SHENG GENERAL HOSPITAL   (Taiwan)

^d KAGOSHIMA UNIVERSITY   (Japan)

^e CHENG HSIN GENERAL HOSPITAL   (Taiwan)

Author keywords

Cardiovascular risk; Gastric bypass; Glucose homeostasis; Insulin secretion; Interleukin 1 ; Sleeve gastrectomy

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; C PEPTIDE; CHOLECYSTOKININ; CHOLESTEROL; GASTROINTESTINAL HORMONE; GHRELIN; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INTERLEUKIN 1BETA; LEPTIN; PEPTIDE YY; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AREA UNDER THE CURVE; ARTICLE; ASIAN; BODY MASS; CARDIOVASCULAR RISK; CELL FUNCTION; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; DIET RESTRICTION; DISEASE CONTROL; DISEASE DURATION; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HOMEOSTASIS; HORMONE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RELEASE; ISCHEMIC HEART DISEASE; LEUKOCYTE COUNT; MALE; MOLECULAR MECHANICS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; POSTOPERATIVE PERIOD; PROTEIN BLOOD LEVEL; RACE; REMISSION; RISK REDUCTION; SLEEVE GASTRECTOMY; STOMACH BYPASS; SURGICAL PATIENT; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

ADIPOKINES; ADULT; CARDIOVASCULAR DISEASES; CYTOKINES; DIABETES MELLITUS, TYPE 2; FEMALE; GASTRECTOMY; GASTRIC BYPASS; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INTERLEUKIN-1BETA; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84877956608     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/0929867311320180008     Document Type: Article

References (32)

1. Chang, H.Y.; Hsu, C.C.; Pan, W.H.; Liu, W.L.; Cheng, J.Y.; Tseng, C.H.; Bai, C.H.; Yeh, W.T.; Hurng, B.S. Gender differences in trends in diabetes prevalence from 1993 to 2008 in Taiwan. Diabetes Res. Clin. Pract., 2010, 90, 358-364.
2. Schauer, P.R.; Kashyap, S.R.; Wolski, K.; Brethauer, S.A.; Kirwan, J.P.; Pothier, C.E.; Thomas, S.; Abood, B.; Nissen, S.E.; Bhatt, D.L. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N. Engl. J. Med., 2012, 366, 1567-1576.
3. Pontiroli, A.E.; Morabito, A. Long-term prevention of mortality in morbid obesity through bariatric surgery. a systematic review and meta-Analysis of trials performed with gastric banding and gastric bypass. Ann. Surg., 2011, 253, 484-487.
4. Lee, W.J.; Chong, K.; Ser, K.H.; Lee, Y.C.; Chen, S.C.; Chen, J.C.; Tsai, M.H.; Chuang, L.M. Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial. Arch. Surg., 2011, 146, 143-148.
5. Yajnik, C.S.; Yudkin, J.S. The Y-Y paradox. Lancet, 2004, 363, 163.
6. Mealey, B.L.; Rose, L.F. Diabetes mellitus and inflammatory periodontal diseases. Curr. Opin. Endocrinol. Diabetes. Obes., 2008, 15, 135-141.
7. Chen, C.Y.; Asakawa, A.; Fujimiya, M.; Lee, S.D., Inui, A. Ghrelin gene products and the regulation of food intake and gut motility. Pharmacol. Rev., 2009, 61, 430-481.
8. Chen, C.Y.; Fujimiya, M.; Laviano, A.; Chang, F.Y.; Lin, H.C.; Lee, S.D. Modulation of ingestive behavior and gastrointestinal motility by ghrelin in diabetic animals and humans. J. Chin. Med. Assoc., 2010, 73, 225-229.
9. Buse, J.B.; Caprio, S.; Cefalu, W.T.; Ceriello, A.; Del Prato, S.; Inzucchi, S.E.; McLaughlin, S.; Phillips, G.L. 2nd.; Robertson, R.P.; Rubino, F.; Kahn, R.; Kirkman, M.S. How do we define cure of diabetes? Diabetes Care, 2009, 32, 2133-2135.
10. International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care, 2009, 32, 1327-1334.
11. Lee, W.J.; Ser, K.H.; Chong, K.; Lee, Y.C.; Chen, S.C.; Tsou, J.J.; Chen, J.C.; Chen, C.M. Laparoscopic sleeve gastrectomy for diabetes treatment in nonmorbidly obese patients: efficacy and change of insulin secretion. Surgery, 2010, 147, 664-669.
12. Lee, W.J.; Chong, K.; Chen, C.Y.; Chen, S.C.; Lee, Y.C.; Ser, K.H.; Chuang, L.M. Diabetes remission and insulin secretion after gastric bypass in patients with body mass index <35 Kg/m2. Obes. Surg., 2011, 21, 889-895.
13. Lee, W.J.; Chen, C.Y.; Chong, K.; Lee, Y.C.; Chen, S.C.; Lee, S.D. Changes in postprandial gut hormones after metabolic surgery: a comparison of gastric bypass and sleeve gastrectomy. Surg. Obes. Relat. Dis., 2011, 7, 683-690.
14. DeBoer, M.D.; Zhu, X.; Levasseur, P.R.; Inui, A.; Hu, Z.; Han, G.; Mitch, W.E.; Taylor, J.E.; Halem, H.A.; Dong, J.Z.; Datta, R.; Culler, M.D.; Marks, D.L. Ghrelin treatment of chronic kidney disease: improvements in lean body mass and cytokine profile. Endocrinology, 2008, 149, 827-835.
15. Stratton, I.M.; Adler, A.I.; Neil, H.A.; Matthews, D.R.; Manley, S.E.; Cull, C.A.; Hadden, D.; Turner, R.C.; Holman, R.R. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ, 2000, 321, 405-412.
16. Vidal, J.; Ibarzabal, A.; Romero, F.; Delgado, S.; Momblán, D.; Flores, L.; Lacy, A. Type 2 diabetes mellitus and the metabolic syndrome following sleeve gastrectomy in severely obese subjects. Obes. Surg., 2008, 18, 1077-1082.
17. Lee, W.J.; Wang, W.; Lee, Y.C.; Huang, M.T.; Ser, K.H.; Chen, J.C. Effect of laparoscopic mini-gastric bypass for type 2 diabetes mellitus: comparison of BMI> 35 and <35 kg/m2. J. Gastrointest. Surg., 2008, 12, 945-952.
18. Service, G.J.; Thompson, G.B.; Service, F.J.; Andrews, J.C.; Collazo-Clavell, M.L.; Lloyd, R.V. Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery. N. Engl. J. Med., 2005, 353, 249-254.
19. Rumilla, K.M.; Erickson, L.A.; Service, F.J.; Vella, A.; Thompson, G.B.; Grant, C.S.; Lloyd, R.V. Hyperinsulinemic hypoglycemia with nesidioblastosis: histologic features and growth factor expression. Mod. Pathol., 2009, 22, 239-245.
20. Seino, S.; Shibasaki, T.; Minami, K. Dynamics of insulin secretion and the clinical implications for obesity and diabetes. J. Clin. Invest., 2011, 121, 2118-2125.
21. Bendtzen, K.; Mandrup-Poulsen, T.; Nerup, J.; Nielsen, J.H.; Dinarello, C.A.; Svenson, M. Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans. Science, 1986, 232, 1545-1547.
22. Maedler, K.; Sergeev, P.; Ris, F.; Oberholzer, J.; Joller-Jemelka, H.I.; Spinas, G.A.; Kaiser, N.; Halban, P.A.; Donath, M.Y. Glucoseinduced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets. J. Clin. Invest., 2002, 110, 851-860.
23. Wogensen, L.D.; Reimers, J.; Nerup, J.; Kolb-Bachofen, V.; Kröncke, K.D.; Almdal, T.; Mandrup-Poulsen, T. Repetitive in vivo treatment with human recombinant interleukin-1 beta modifies beta-cell function in normal rats. Diabetologia, 1992, 35, 331-339.
24. Reimers, J.I.; Bjerre, U.; Mandrup-Poulsen, T.; Nerup, J. Interleukin 1 beta induces diabetes and fever in normal rats by nitric oxide via induction of different nitric oxide synthases. Cytokine, 1994, 6, 512-520.
25. Larsen, C.M.; Faulenbach, M.; Vaag, A.; Vølund, A.; Ehses, J.A.; Seifert, B.; Mandrup-Poulsen, T.; Donath, M.Y. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N. Engl. J. Med., 2007, 356, 1517-1526.
26. Donath, M.Y.; Weder, C.; Brunner, A.; Keller, C.; Whitmore, J.; Der, K.; Zayed, H.; Scannon, P.J.; Feldstein, J.D.; Dinarello, C.A.; Solinger, A.M. XOMA 052, a potential disease modifying anti-IL-1 beta antibody, shows sustained HbA1c reductions 3 months after a single injection with no increases in safety parameters in subjects with type 2 diabetes. Diabetes, 2009, 58, A30.
27. Larsen, C.M.; Faulenbach, M.; Vaag, A.; Ehses, J.A.; Donath, M.Y.; Mandrup-Poulsen, T. Sustained effects of interleukin-1 receptor antagonist treatment in type 2 diabetes. Diabetes Care, 2009, 32, 1663-1668.
28. Toda, Y.; Tsukada, J.; Misago, M.; Kominato, Y.; Auron, P.E.; Tanaka, Y. Autocrine induction of the human pro-IL-1beta gene promoter by IL-1beta in monocytes. J. Immunol., 2002, 168, 1984-1991.
29. Stienstra, R.; Joosten, L.A.; Koenen, T.; van Tits, B.; van Diepen, J.A.; van Den Berg, S.A.; Rensen, P.C.; Voshol, P.J.; Fantuzzi, G.; Hijmans, A.; Kersten, S.; Müller, M.; van Den Berg, W.B.; van Rooijen, N.; Wabitsch, M.; Kullberg, B.J.; van der Meer, J.W.; Kanneganti, T.; Tack, C.J.; Netea, M.G. The inflammasomemediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity. Cell Metab., 2010, 12, 593-605.
30. Maedler, K.; Schumann, D.M.; Sauter, N.; Ellingsgaard, H.; Bosco, D.; Baertschiger, R.; Iwakura, Y.; Oberholzer, J.; Wollheim, C.B.; Gauthier, B.R.; Donath, M.Y. Low concentration of interleukin-1beta induces FLICE-inhibitory protein-mediated beta-cell proliferation in human pancreatic islets. Diabetes, 2006, 55, 2713-2722.
31. Böni-Schnetzler, M.; Donath, M.Y. Increased IL-1α activation, the culprit not only for defective insulin secretion but also for insulin resistance? Cell Res., 2011, 21, 995-997.
32. Michalakis, K.; le Roux, C. Gut hormones and leptin: impact on energy control and changes after bariatric surgery-What the future holds. Obes. Surg., 2012, 22, 1648-1657.